Pharmacist-Led Program Improves Hypertrophic Cardiomyopathy Outcomes

The first-in-class cardiac myosin inhibitor Camzyos can be an effective treatment for hypertrophic cardiomyopathy, but cardiac risks associated with the drug require that specialty pharmacists help with its dispensing, according to data presented at the ASHP Pharmacy Futures 2025 meeting.